Psoriasis drug study halted midway: what it means for patients
Disease control
Terminated
This study tested the long-term safety and effectiveness of the drug imsidolimab for adults with generalized pustular psoriasis (GPP), a severe skin condition. Participants had already completed an earlier phase of the study. The study was terminated early, and results are not ye…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC